Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Gattinoni

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|July 28, 2007
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signalingChrystal M Paulos, Claudia Wrzesinski, Andrew Kaiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Toll-like receptors in tumor immunotherapyChrystal M Paulos, Andrew Kaiser, Claudia Wrzesinski, et al.
Human Gene Therapy|April 4, 2014
A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancerDaniel Abate-Daga, Kiran H Lagisetty, Eric Tran, et al.
Blood|May 27, 2016
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignanciesMarianna Sabatino, Jinhui Hu, Michele Sommariva, et al.
The Journal of Experimental Medicine|October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsLuca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
Science Immunology|December 27, 2016
The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemnessTuoqi Wu, Yun Ji, E Ashley Moseman, et al.
Nature Immunology|November 8, 2011
Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cellsYun Ji, Zoltan Pos, Mahadev Rao, et al.
The Journal of Clinical Investigation|October 5, 2013
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor functionMadhusudhanan Sukumar, Jie Liu, Yun Ji, et al.
Cancer Research|July 22, 2010
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hostsSid P Kerkar, Pawel Muranski, Andrew Kaiser, et al.
The Journal of Clinical Investigation|January 3, 2013
Superior T memory stem cell persistence supports long-lived T cell memoryEnrico Lugli, Maria H Dominguez, Luca Gattinoni, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|July 28, 2007
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signalingChrystal M Paulos, Claudia Wrzesinski, Andrew Kaiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Toll-like receptors in tumor immunotherapyChrystal M Paulos, Andrew Kaiser, Claudia Wrzesinski, et al.
Human Gene Therapy|April 4, 2014
A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancerDaniel Abate-Daga, Kiran H Lagisetty, Eric Tran, et al.
Blood|May 27, 2016
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignanciesMarianna Sabatino, Jinhui Hu, Michele Sommariva, et al.
The Journal of Experimental Medicine|October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsLuca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
Science Immunology|December 27, 2016
The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemnessTuoqi Wu, Yun Ji, E Ashley Moseman, et al.
Nature Immunology|November 8, 2011
Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cellsYun Ji, Zoltan Pos, Mahadev Rao, et al.
The Journal of Clinical Investigation|October 5, 2013
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor functionMadhusudhanan Sukumar, Jie Liu, Yun Ji, et al.
Cancer Research|July 22, 2010
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hostsSid P Kerkar, Pawel Muranski, Andrew Kaiser, et al.
The Journal of Clinical Investigation|January 3, 2013
Superior T memory stem cell persistence supports long-lived T cell memoryEnrico Lugli, Maria H Dominguez, Luca Gattinoni, et al.
Pageof 12